[1]
|
Hsieh, J.J., Purdue, M.P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D.Y., Larkin, J. and Ficarra, V. (2017) Renal Cell Carcinoma. Nature Reviews Disease Primers, 3, Article No. 17009.
https://doi.org/10.1038/nrdp.2017.9
|
[2]
|
Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Piva, F., Modena, A., Bimbatti, D., Fantinel, E., Santini, D., Cheng, L., Cascinu, S., Montironi, R. and Tortora, G. (2015) Metabolic Altera-tions in Renal Cell Carcinoma. Cancer Treatment Reviews, 41, 767-776. https://doi.org/10.1016/j.ctrv.2015.07.002
|
[3]
|
Hsu, C.C., Peng, D., Cai, Z. and Lin, H.K. (2022) AMPK Signaling and Its Targeting in Cancer Progression and Treatment. Seminars in Cancer Biology, 85, 52-68. https://doi.org/10.1016/j.semcancer.2021.04.006
|
[4]
|
Yan, Y., Zhou, X.E., Xu, H.E. and Melcher, K. (2018) Structure and Physiological Regulation of AMPK. International Journal of Molecular Sciences, 19, Article 3534. https://doi.org/10.3390/ijms19113534
|
[5]
|
Li, M., Verdijk, L.B., Sakamoto, K., Ely, B., van Loon, L.J. and Musi, N. (2012) Reduced AMPK-ACC and mTOR Signaling in Muscle from Older Men, and Effect of Resistance Exercise. Mechanisms of Ageing and Development, 133, 655-664. https://doi.org/10.1016/j.mad.2012.09.001
|
[6]
|
Yavari, A., Stocker, C.J., Ghaffari, S., Wargent, E.T., Steeples, V., Czibik, G., Pinter, K., Bellahcene, M., Woods, A., Martinez De Morentin, P.B., Cansell, C., Lam, B.Y., Chuster, A., Petkevicius, K., Nguyen-Tu, M.S., Martinez-Sanchez, A., Pullen, T.J., Oliver, P.L., Stockenhuber, A., Nguyen, C., Lazdam, M., O’Dowd, J.F., Harikumar, P., Toth, M., Beall, C., Kyria-kou, T., Parnis, J., Sarma, D., Katritsis, G., Wortmann, D.D., Harper, A.R., Brown, L.A., Willows, R., Gandra, S., Pon-cio, V., de Oliveira Figueiredo, M.J., Qi, N.R., Peirson, S.N., McCrimmon, R.J., Gereben, B., Tretter, L., Fekete, C., Redwood, C., Yeo, G.S., Heisler, L.K., Rutter, G.A., Smith, M.A., Withers, D.J., Carling, D., Sternick, E.B., Arch, J.R., Cawthorne, M.A., Watkins, H. and Ashrafian, H. (2016) Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. Cell Metabolism, 23, 821-836. https://doi.org/10.1016/j.cmet.2016.04.003
|
[7]
|
Wang, Z.Y., Wang, N., Liu, P.X. and Xie, X. (2016) AMPK and Cancer. In: Cordero, M. and Viollet, B., Eds., AMP-Activated Protein Ki-nase, Springer, Cham, 203-226. https://doi.org/10.1007/978-3-319-43589-3_9
|
[8]
|
Ciccarese, F., Zulato, E. and Indraccolo, S. (2019) LKB1/AMPK Pathway and Drug Response in Cancer: A Therapeutic Perspective. Oxidative Medi-cine and Cellular Longevity, 2019, Article ID: 8730816.
https://doi.org/10.1155/2019/8730816
|
[9]
|
Charbonneau, M., Harper, K., Brochu-Gaudreau, K., Perreault, A., McDonald, P.P., Ekindi-Ndongo, N., Jeldres, C. and Dubois, C.M. (2022) Establishment of a ccRCC Patient-Derived Chick Chorioallantoic Membrane Model for Drug Testing. Frontiers in Medicine, 9. https://doi.org/10.3389/fmed.2022.1003914
|
[10]
|
Mendhiratta, N., Muraki, P., Sisk Jr., A.E. and Shuch, B. (2021) Papillary Renal Cell Carcinoma: Review. Urologic Oncology: Seminars and Original Investigations, 39, 327-337. https://doi.org/10.1016/j.urolonc.2021.04.013
|
[11]
|
Wettersten, H.I., Aboud, O.A., Lara, P.J. and Weiss Jr., R.H. (2017) Metabolic Reprogramming in Clear Cell Renal Cell Carcinoma. Nature Reviews Nephrology, 13, 410-419. https://doi.org/10.1038/nrneph.2017.59
|
[12]
|
Wang, Q., Liu, S., Zhai, A., Zhang, B. and Tian, G. (2018) AMPK-Mediated Regulation of Lipid Metabolism by Phosphorylation. Biological and Pharmaceutical Bulletin, 41, 985-993. https://doi.org/10.1248/bpb.b17-00724
|
[13]
|
Li, C., Liu, V.W., Chiu, P.M., Chan, D.W. and Ngan, H.Y.S. (2012) Over-Expressions of AMPK Subunits in Ovarian Carcinomas with Significant Clinical Implications. BMC Can-cer, 12, Article No. 357.
https://doi.org/10.1186/1471-2407-12-357
|
[14]
|
Gao, Y., Paivinen, P., Tripathi, S., Chan, D.W. and Ngan, H.Y. (2022) Inactivation of AMPK Leads to Attenuation of Antigen Presentation and Immune Evasion in Lung Adenocarci-noma. Clinical Cancer Research, 28, 227-237.
https://doi.org/10.1158/1078-0432.CCR-21-2049
|
[15]
|
Wang, Y., Yi, Y., Yao, J., Wan, H., Yu, M., Ge, L., Zeng, X., Wu, M. and Mei, L. (2022) Isoginkgetin Synergizes with Doxorubicin for Robust Co-Delivery to Induce Autophagic Cell Death in Hepatocellular Carcinoma. Acta Biomaterialia, 153, 518-528. https://doi.org/10.1016/j.actbio.2022.09.035
|